Seattle Genetics Inc.

Available to platforms

Seattle Genetics, Inc. is a biotechnology company that develops monoclonal antibody-based drugs for the treatment of cancer and related diseases, as well as offers technology for creating 'antibody-drug conjugates' for delivering drugs directly to tumor cells. The company serves clients in the northwestern part of the United States.

Seattle Genetics Inc. - SGEN stocks live chart

Analyze price movements of Seattle Genetics Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous SGEN quotes – including the latest bid at 228.89 USD and ask at 228.91 USD – and get all the necessary information for adding Seattle Genetics Inc. to your investment portfolio.

With R StocksTrader, you can invest in Seattle Genetics Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Seattle Genetics Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of SGEN does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Seattle Genetics Inc. (SGEN).

You can trade Seattle Genetics Inc. (SGEN) on the R StocksTrader platform.

You can trade online Seattle Genetics Inc. (SGEN) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts